I had this test done and the results will be back 2/12/13.
It was in the Wall Street Journal on 12/29/12 and I took the article to my Onc and he contacted them and made arrangements. The test was performed on prior biopsy from my lung. They said they would work with my insurance company, or something about there being funding?
Matching a Tumor to a Drug....Our growing understanding of the workings of the human genome is posing a new challenge. How to use the data to change the course of disease. Consider cancer. As seen through a gene sequencing machine some cancers can appear as at least a dozen different genetic diseases, some of which have been shown to respond uniquely to a specific drug. But how do doctors quickly match a patients tumor with a drug that targets it?
One answer is a test developed by Foundation Medicine Inc. a Cambridge Mass startup whose scientific founders include one of the leaders of the Human Genome Project.. The test, officially launched last June enables doctors to test a tumor sample for 280 different genetic mutations suspected of driving tumor growth.
This changes everything in terms of how we approach patients with cancer says David Spigel, director of lung cancer research at the Sarah Cannon Research Institute in Nashville, Tenn. He used the test in one patient with advanced disease and few apparent options. She turned out positive for an alteration in a gene targeted by several drugs currently in development. She signed up for one of the studies. A short time later she is like a new person he says. She's off pain medicine. She gained her weight back.
Michael Pelini, Foundation's chief executive officer, says that more than 600 oncologists have requested the test, which lists for 5,800.So far he says, about 70percent of cases have turned up a mutation that is potentially targeted by a drug on the market or in a clinical trial.
In one recent case, Dr. Pellini says, a sample from a woman with advanced pancreatic cancer yielded a response for "her2" an alteration associated with a certain form of breast cancer. She was treated and her cancer responded to the breast cancer drug Herceptin. Few oncologists would think to look for her2 in a patient with pancreatic cancer, he said.
NOTE: I've gone through a lot of chemos in a short time and hope this will direct me to the best clinical trial eventually. Janz